These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 19068395

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Mechanisms of disease: adrenocortical tumors--molecular advances and clinical perspectives.
    Bertherat J, Groussin L, Bertagna X.
    Nat Clin Pract Endocrinol Metab; 2006 Nov; 2(11):632-41. PubMed ID: 17082810
    [Abstract] [Full Text] [Related]

  • 3. Molecular markers and long-term recurrences in a large cohort of patients with sporadic adrenocortical tumors.
    Gicquel C, Bertagna X, Gaston V, Coste J, Louvel A, Baudin E, Bertherat J, Chapuis Y, Duclos JM, Schlumberger M, Plouin PF, Luton JP, Le Bouc Y.
    Cancer Res; 2001 Sep 15; 61(18):6762-7. PubMed ID: 11559548
    [Abstract] [Full Text] [Related]

  • 4. Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors.
    Tissier F, Cavard C, Groussin L, Perlemoine K, Fumey G, Hagneré AM, René-Corail F, Jullian E, Gicquel C, Bertagna X, Vacher-Lavenu MC, Perret C, Bertherat J.
    Cancer Res; 2005 Sep 01; 65(17):7622-7. PubMed ID: 16140927
    [Abstract] [Full Text] [Related]

  • 5. Rearrangements at the 11p15 locus and overexpression of insulin-like growth factor-II gene in sporadic adrenocortical tumors.
    Gicquel C, Bertagna X, Schneid H, Francillard-Leblond M, Luton JP, Girard F, Le Bouc Y.
    J Clin Endocrinol Metab; 1994 Jun 01; 78(6):1444-53. PubMed ID: 7911125
    [Abstract] [Full Text] [Related]

  • 6. Role of the insulin-like growth factor system in adrenocortical growth control and carcinogenesis.
    Fottner Ch, Hoeflich A, Wolf E, Weber MM.
    Horm Metab Res; 2004 Jun 01; 36(6):397-405. PubMed ID: 15241731
    [Abstract] [Full Text] [Related]

  • 7. New insights in the genetics of adrenocortical tumors, pheochromocytomas and paragangliomas.
    Bertherat J, Gimenez-Roqueplo AP.
    Horm Metab Res; 2005 Jun 01; 37(6):384-90. PubMed ID: 16001332
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Insulin-like growth factor system on adrenocortical tumorigenesis.
    Ribeiro TC, Latronico AC.
    Mol Cell Endocrinol; 2012 Mar 31; 351(1):96-100. PubMed ID: 22019903
    [Abstract] [Full Text] [Related]

  • 11. Molecular markers and the pathogenesis of adrenocortical cancer.
    Soon PS, McDonald KL, Robinson BG, Sidhu SB.
    Oncologist; 2008 May 31; 13(5):548-61. PubMed ID: 18515740
    [Abstract] [Full Text] [Related]

  • 12. The molecular pathogenesis of childhood adrenocortical tumors.
    Almeida MQ, Latronico AC.
    Horm Metab Res; 2007 Jun 31; 39(6):461-6. PubMed ID: 17578765
    [Abstract] [Full Text] [Related]

  • 13. Wnt/beta-catenin and 3',5'-cyclic adenosine 5'-monophosphate/protein kinase A signaling pathways alterations and somatic beta-catenin gene mutations in the progression of adrenocortical tumors.
    Gaujoux S, Tissier F, Groussin L, Libé R, Ragazzon B, Launay P, Audebourg A, Dousset B, Bertagna X, Bertherat J.
    J Clin Endocrinol Metab; 2008 Oct 31; 93(10):4135-40. PubMed ID: 18647815
    [Abstract] [Full Text] [Related]

  • 14. Somatic TP53 mutations are relatively rare among adrenocortical cancers with the frequent 17p13 loss of heterozygosity.
    Libè R, Groussin L, Tissier F, Elie C, René-Corail F, Fratticci A, Jullian E, Beck-Peccoz P, Bertagna X, Gicquel C, Bertherat J.
    Clin Cancer Res; 2007 Feb 01; 13(3):844-50. PubMed ID: 17289876
    [Abstract] [Full Text] [Related]

  • 15. [Pathogenesis of adrenocortical cancer].
    Szabó D, Zsippai A, Bendes M, Tömböl Z, Szabó PM, Rácz K, Igaz P.
    Orv Hetil; 2010 Jul 18; 151(29):1163-70. PubMed ID: 20591784
    [Abstract] [Full Text] [Related]

  • 16. Mutations in adrenocortical tumors.
    Reincke M.
    Horm Metab Res; 1998 Jul 18; 30(6-7):447-55. PubMed ID: 9694578
    [Abstract] [Full Text] [Related]

  • 17. Pathogenesis of adrenocortical cancer.
    Bertherat J, Bertagna X.
    Best Pract Res Clin Endocrinol Metab; 2009 Apr 18; 23(2):261-71. PubMed ID: 19500768
    [Abstract] [Full Text] [Related]

  • 18. Structural and functional abnormalities at 11p15 are associated with the malignant phenotype in sporadic adrenocortical tumors: study on a series of 82 tumors.
    Gicquel C, Raffin-Sanson ML, Gaston V, Bertagna X, Plouin PF, Schlumberger M, Louvel A, Luton JP, Le Bouc Y.
    J Clin Endocrinol Metab; 1997 Aug 18; 82(8):2559-65. PubMed ID: 9253334
    [Abstract] [Full Text] [Related]

  • 19. Mutational analysis of PRKAR1A and Gs(alpha) in sporadic adrenocortical tumors.
    Libé R, Mantovani G, Bondioni S, Lania AG, Pedroni C, Beck-Peccoz P, Spada A.
    Exp Clin Endocrinol Diabetes; 2005 May 18; 113(5):248-51. PubMed ID: 15926108
    [Abstract] [Full Text] [Related]

  • 20. Pediatric adrenocortical tumors: molecular events leading to insulin-like growth factor II gene overexpression.
    Wilkin F, Gagné N, Paquette J, Oligny LL, Deal C.
    J Clin Endocrinol Metab; 2000 May 18; 85(5):2048-56. PubMed ID: 10843195
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.